Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
40 hedge funds and large institutions have $108M invested in Flexion Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$30.8M |
| 2 |
Jennison Associates
New York
|
+$12.6M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$12.5M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$8.53M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$7.78M |
Top Sellers
FLXN Hedge Fund Activity: Q1 2014 in Review
40 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q1 2014, worth a combined $108M.
Buyers outnumbered sellers: 40 funds opened new FLXN positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $30.8M.
- 40 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q1 2014, up from 0 in Q4 2013.
- Funds reported $108M of Flexion Therapeutics, Inc. stock for Q1 2014.
- 40 funds opened new Flexion Therapeutics, Inc. positions in Q1 2014 and 0 closed out, a net change of +40 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q1 2014 was Novo Holdings A/S, an estimated $30.8M added.
Based on aggregated 13F filings for Q1 2014.